Lv4
490 积分 2025-05-31 加入
Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review
3分钟前
待确认
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
2天前
已完结
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment
1个月前
已完结
Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia
3个月前
已完结
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations
4个月前
已完结
Rationale for Hepatitis C Virus Treatment During Hematopoietic Stem Cell Transplant in the Era of Novel Direct-Acting Antivirals
4个月前
已完结
Conditioning Regimen Options
4个月前
已完结
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
4个月前
已完结
Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia
4个月前
已完结
皖公网安备34019202002308
